Compare $ADMA vs $IMNM | Chartloom

Compare

$ADMA vs $IMNM

ADMA Biologics Inc · Immunome Inc

ADMA

ADMA Biologics Inc

IMNM

Immunome Inc

Compare $ADMA vs $IMNM

Comparing ADMA Biologics Inc and Immunome Inc

ADMAADMA Biologics Inc

IMNMImmunome Inc

ADMAADMA Biologics Inc

Market cap

$2.40B

P/E (TTM)

14.12x

Forward P/E (NTM)

12.78x

Forward P/S (NTM)

4.05x

Rev growth (TTM)

8.0%

YTD performance

-42.1%

52W performance

-29.1%

FCF yield

4.8%

IMNMImmunome Inc

Market cap

$2.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

127.50x

Rev growth (TTM)

-100.0%

YTD performance

-6.1%

52W performance

39.5%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADMA

IMNM

Detailed metrics comparison

ADMA

ADMA Biologics Inc

IMNM

Immunome Inc

Market Cap

ADMA$2.40B

IMNM$2.21B

Enterprise Value

ADMA$2.46B

IMNM$2.00B

Price

ADMA$10.36

IMNM$19.55

P/E Ratio

ADMA14.12x

IMNMN/A

P/S Ratio

ADMA4.69x

IMNM188.56x

EV/Sales

ADMA4.81x

IMNM171.27x

EV/EBITDA

ADMA11.39x

IMNM0.00x

P/B Ratio

ADMA5.33x

IMNM4.52x

P/FCF Ratio

ADMA20.66x

IMNMN/A

EV/FCF

ADMA21.18x

IMNM-8.75x

PEG Ratio

ADMAN/A

IMNMN/A

Forward P/E (NTM)

ADMA12.78x

IMNMN/A

Forward P/S (NTM)

ADMA4.05x

IMNM127.50x

Revenue (TTM)

ADMA$512M

IMNM$0

Revenue Growth (YoY)

ADMA8.0%

IMNM-100.0%

Forward Rev Growth

ADMA17.6%

IMNM15247.2%

Gross Margin (TTM)

ADMA64.7%

IMNM0.0%

Operating Margin (TTM)

ADMA43.4%

IMNM0.0%

EBITDA Margin (TTM)

ADMA42.2%

IMNM0.0%

Net Margin (TTM)

ADMA33.0%

IMNM0.0%

FCF Margin (TTM)

ADMA22.7%

IMNMN/A

Net Income (TTM)

ADMA$169M

IMNM$-254M

FCF (TTM)

ADMA$116M

IMNM$-228M

EPS (TTM)

ADMA$0.73

IMNM-$2.25

ROE (TTM)

ADMA39.6%

IMNM-5056.0%

ROA (TTM)

ADMA26.6%

IMNM-4693.0%

ROIC (TTM)

ADMA30.1%

IMNM-5056.0%

Cash

ADMA$136M

IMNM$218M

Debt

ADMA$197M

IMNM$0

Net Cash/Debt

ADMA$-61M

IMNM$218M

Current Ratio (TTM)

ADMA6.97x

IMNM15.08x

Quick Ratio (TTM)

ADMA3.62x

IMNM14.56x

Debt/Equity (TTM)

ADMA0.48x

IMNM0.00x

Debt/Assets (TTM)

ADMA0.0%

IMNM0.0%

Interest Coverage (TTM)

ADMAN/A

IMNMN/A

Net Debt/EBITDA (TTM)

ADMA0.00x

IMNM0.00x

Beta

ADMA0.70

IMNM2.65

52W Performance

ADMA-29.1%

IMNM39.5%

YTD Performance

ADMA-42.1%

IMNM-6.1%

% from 52W High

ADMA-49.4%

IMNM-35.0%

% from 52W Low

ADMA43.7%

IMNM44.9%

Asset Turnover (TTM)

ADMA0.81x

IMNM0.04x

FCF Yield (TTM)

ADMA4.8%

IMNM-10.3%

Earnings Yield (TTM)

ADMA7.0%

IMNM-11.5%

Dividend Yield (TTM)

ADMAN/A

IMNMN/A

Rule of 40

ADMA30.7

IMNM-100.0

EV/GP/RG

ADMA0.47

IMNMN/A

Ticker research

View ADMA research View IMNM research

Metric	ADMA ADMA Biologics Inc	IMNM Immunome Inc
Market & Valuation
Market Cap	$2.40B	$2.21B
Enterprise Value	$2.46B	$2.00B
Price	$10.36	$19.55
P/E Ratio	14.12x	N/A
P/S Ratio	4.69x	188.56x
EV/Sales	4.81x	171.27x
EV/EBITDA	11.39x	0.00x
P/B Ratio	5.33x	4.52x
P/FCF Ratio	20.66x	N/A
EV/FCF	21.18x	-8.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	12.78x	N/A
Forward P/S (NTM)	4.05x	127.50x
Revenue & Growth
Revenue (TTM)	$512M	$0
Revenue Growth (YoY)	8.0%	-100.0%
Forward Rev Growth	17.6%	15247.2%
Profitability
Gross Margin (TTM)	64.7%	0.0%
Operating Margin (TTM)	43.4%	0.0%
EBITDA Margin (TTM)	42.2%	0.0%
Net Margin (TTM)	33.0%	0.0%
FCF Margin (TTM)	22.7%	N/A
Net Income (TTM)	$169M	$-254M
FCF (TTM)	$116M	$-228M
EPS (TTM)	$0.73	-$2.25
ROE (TTM)	39.6%	-5056.0%
ROA (TTM)	26.6%	-4693.0%
ROIC (TTM)	30.1%	-5056.0%
Financial Health
Cash	$136M	$218M
Debt	$197M	$0
Net Cash/Debt	$-61M	$218M
Current Ratio (TTM)	6.97x	15.08x
Quick Ratio (TTM)	3.62x	14.56x
Debt/Equity (TTM)	0.48x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.70	2.65
52W Performance	-29.1%	39.5%
YTD Performance	-42.1%	-6.1%
% from 52W High	-49.4%	-35.0%
% from 52W Low	43.7%	44.9%
Efficiency & Yields
Asset Turnover (TTM)	0.81x	0.04x
FCF Yield (TTM)	4.8%	-10.3%
Earnings Yield (TTM)	7.0%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.7	-100.0
EV/GP/RG	0.47	N/A
Ticker research	View ADMA research	View IMNM research

Valuation

P/E Ratio

ADMA

14.12x

P/S Ratio

ADMA

4.69x

IMNM

188.56x

EV/FCF

IMNM

-8.75x

ADMA

21.18x

Growth & revenue

Revenue Growth TTM

ADMA

8.0%

IMNM

-100.0%

Forward Revenue Growth

IMNM

15247.2%

ADMA

17.6%

Profitability & performance

Gross Margin

ADMA

64.7%

IMNM

0.0%

ROE

ADMA

39.6%

IMNM

-5056.0%

FCF Yield %

ADMA

4.8%

IMNM

-10.3%

52-Week Performance

IMNM

39.5%

ADMA

-29.1%

Detailed metrics comparison

ADMA

ADMA Biologics Inc

IMNM

Immunome Inc

Market Cap

ADMA$2.40B

IMNM$2.21B

Enterprise Value

ADMA$2.46B

IMNM$2.00B

Price

ADMA$10.36

IMNM$19.55

P/E Ratio

ADMA14.12x

IMNMN/A

P/S Ratio

ADMA4.69x

IMNM188.56x

EV/Sales

ADMA4.81x

IMNM171.27x

EV/EBITDA

ADMA11.39x

IMNM0.00x

P/B Ratio

ADMA5.33x

IMNM4.52x

P/FCF Ratio

ADMA20.66x

IMNMN/A

EV/FCF

ADMA21.18x

IMNM-8.75x

PEG Ratio

ADMAN/A

IMNMN/A

Forward P/E (NTM)

ADMA12.78x

IMNMN/A

Forward P/S (NTM)

ADMA4.05x

IMNM127.50x

Revenue (TTM)

ADMA$512M

IMNM$0

Revenue Growth (YoY)

ADMA8.0%

IMNM-100.0%

Forward Rev Growth

ADMA17.6%

IMNM15247.2%

Gross Margin (TTM)

ADMA64.7%

IMNM0.0%

Operating Margin (TTM)

ADMA43.4%

IMNM0.0%

EBITDA Margin (TTM)

ADMA42.2%

IMNM0.0%

Net Margin (TTM)

ADMA33.0%

IMNM0.0%

FCF Margin (TTM)

ADMA22.7%

IMNMN/A

Net Income (TTM)

ADMA$169M

IMNM$-254M

FCF (TTM)

ADMA$116M

IMNM$-228M

EPS (TTM)

ADMA$0.73

IMNM-$2.25

ROE (TTM)

ADMA39.6%

IMNM-5056.0%

ROA (TTM)

ADMA26.6%

IMNM-4693.0%

ROIC (TTM)

ADMA30.1%

IMNM-5056.0%

Cash

ADMA$136M

IMNM$218M

Debt

ADMA$197M

IMNM$0

Net Cash/Debt

ADMA$-61M

IMNM$218M

Current Ratio (TTM)

ADMA6.97x

IMNM15.08x

Quick Ratio (TTM)

ADMA3.62x

IMNM14.56x

Debt/Equity (TTM)

ADMA0.48x

IMNM0.00x

Debt/Assets (TTM)

ADMA0.0%

IMNM0.0%

Interest Coverage (TTM)

ADMAN/A

IMNMN/A

Net Debt/EBITDA (TTM)

ADMA0.00x

IMNM0.00x

Beta

ADMA0.70

IMNM2.65

52W Performance

ADMA-29.1%

IMNM39.5%

YTD Performance

ADMA-42.1%

IMNM-6.1%

% from 52W High

ADMA-49.4%

IMNM-35.0%

% from 52W Low

ADMA43.7%

IMNM44.9%

Asset Turnover (TTM)

ADMA0.81x

IMNM0.04x

FCF Yield (TTM)

ADMA4.8%

IMNM-10.3%

Earnings Yield (TTM)

ADMA7.0%

IMNM-11.5%

Dividend Yield (TTM)

ADMAN/A

IMNMN/A

Rule of 40

ADMA30.7

IMNM-100.0

EV/GP/RG

ADMA0.47

IMNMN/A

Ticker research

View ADMA research View IMNM research

Metric	ADMA ADMA Biologics Inc	IMNM Immunome Inc
Market & Valuation
Market Cap	$2.40B	$2.21B
Enterprise Value	$2.46B	$2.00B
Price	$10.36	$19.55
P/E Ratio	14.12x	N/A
P/S Ratio	4.69x	188.56x
EV/Sales	4.81x	171.27x
EV/EBITDA	11.39x	0.00x
P/B Ratio	5.33x	4.52x
P/FCF Ratio	20.66x	N/A
EV/FCF	21.18x	-8.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	12.78x	N/A
Forward P/S (NTM)	4.05x	127.50x
Revenue & Growth
Revenue (TTM)	$512M	$0
Revenue Growth (YoY)	8.0%	-100.0%
Forward Rev Growth	17.6%	15247.2%
Profitability
Gross Margin (TTM)	64.7%	0.0%
Operating Margin (TTM)	43.4%	0.0%
EBITDA Margin (TTM)	42.2%	0.0%
Net Margin (TTM)	33.0%	0.0%
FCF Margin (TTM)	22.7%	N/A
Net Income (TTM)	$169M	$-254M
FCF (TTM)	$116M	$-228M
EPS (TTM)	$0.73	-$2.25
ROE (TTM)	39.6%	-5056.0%
ROA (TTM)	26.6%	-4693.0%
ROIC (TTM)	30.1%	-5056.0%
Financial Health
Cash	$136M	$218M
Debt	$197M	$0
Net Cash/Debt	$-61M	$218M
Current Ratio (TTM)	6.97x	15.08x
Quick Ratio (TTM)	3.62x	14.56x
Debt/Equity (TTM)	0.48x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.70	2.65
52W Performance	-29.1%	39.5%
YTD Performance	-42.1%	-6.1%
% from 52W High	-49.4%	-35.0%
% from 52W Low	43.7%	44.9%
Efficiency & Yields
Asset Turnover (TTM)	0.81x	0.04x
FCF Yield (TTM)	4.8%	-10.3%
Earnings Yield (TTM)	7.0%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.7	-100.0
EV/GP/RG	0.47	N/A
Ticker research	View ADMA research	View IMNM research